Instructions for Sodium Chloride-Darnitsa solution for infusions 0.9% bottle 200 ml
Composition
active ingredient: sodium chloride;
1 ml of solution contains: sodium chloride 9.0 mg;
ionic composition per 1 liter of the drug: Na+ – 154 mmol, Cl¯ – 154 mmol;
excipient: water for injections.
Dosage form
Solution for infusion.
Main physicochemical properties: clear colorless liquid.
Pharmacotherapeutic group
Blood substitutes and perfusion solutions. Electrolyte solutions. ATX code B05X A03.
Pharmacological properties
Pharmacodynamics
0.9% sodium chloride solution normalizes water-salt balance and eliminates fluid deficiency in the human body, which develops during dehydration or due to the accumulation of extracellular fluid in the foci of major burns and injuries, during operations on the abdominal organs, and peritonitis.
0.9% sodium chloride solution improves tissue perfusion, increases the effectiveness of blood transfusion measures in massive blood loss and severe forms of shock.
It also exhibits a detoxification effect due to a short-term increase in fluid volume, a decrease in the concentration of toxic products in the blood, and activation of diuresis.
Pharmacokinetics
Rapidly excreted from the vascular system. The drug is retained in the vascular bed for a short time, after which it passes into the interstitial and intracellular sectors. After 1 hour, only about half of the injected solution remains in the vessels. Very quickly, salts and fluid begin to be excreted by the kidneys, increasing diuresis.
Indication
To replenish the lack of fluid in the body and in the complex of intensive care measures; as a solvent for other compatible drugs. Can be used locally for washing wounds, nasal mucosa, as well as catheters and transfusion systems.
Contraindication
Hyperhydration, hyperchloremia, hypernatremia, chloride acidosis, conditions associated with the risk of developing pulmonary edema.
The drug is not used for washing the eyes during ophthalmic operations.
Interaction with other medicinal products and other types of interactions
The drug is compatible with most medications, so it is used to dissolve various medications – with the exception of those drugs that are incompatible with sodium chloride as a solvent.
Application features
With prolonged administration, especially in large volumes, monitor the level of electrolytes in plasma and urine, as well as diuresis.
It is administered with caution to patients with impaired renal excretory function, with decompensated heart defects, and with edematous-ascites syndrome in patients with liver cirrhosis.
Concomitant administration with corticosteroids or corticotropin requires constant monitoring of blood electrolyte levels.
In cases of shock and blood loss, blood transfusion, plasma transfusion, and plasma substitutes can be performed simultaneously with the use of 0.9% Sodium Chloride solution.
Ability to influence reaction speed when driving vehicles or other mechanisms
No effect.
Use during pregnancy or breastfeeding
The drug can be used according to indications.
Method of administration and doses
It is administered intravenously, rectally, and externally.
Administered intravenously drip up to 3 liters or more of solution per day at a rate of 4 - 10 ml/kg/hour, depending on the clinical situation and the level of fluid loss; administered orally; administered in enemas of 75 - 100 ml; used for washing wounds and mucous membranes.
Children
Children with shock dehydration (without determining laboratory parameters) are administered 20 - 30 ml/kg. In the future, the dosage regimen is adjusted depending on laboratory parameters. The total daily dose depends on the water-electrolyte balance, etc.
Overdose
May lead to chloride acidosis, increased potassium excretion, hyperhydration and hypervolemia, which may lead to heart failure. If symptoms of these conditions appear, the drug should be discontinued, the patient's condition should be assessed and adequate care provided.
Adverse reactions
Not observed with proper use of the drug. When conducting massive infusions, the development of chloride acidosis is possible.
Expiration date
2 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 ° C. Do not freeze. Keep out of the reach of children.
Packaging
200 ml in a bottle.
Vacation category
According to the recipe.
Producer
PrJSC "Pharmaceutical Company "Darnitsa".
Location of the manufacturer and its business address
Ukraine, 02093, Kyiv, Boryspilska St., 13.
